PHAT Stock Analysis: Buy, Sell, or Hold?
PHAT - Phathom Pharmaceuticals, Inc. Common Stock
$13.81
0.00 (0.00%)
▲
5d:
-2.95%
30d:
-12.09%
90d:
+1.92%
HOLD
MODERATE Confidence
Last Updated: February 3, 2026
Earnings: Mar 05, 2026
28d
Get Alerted When PHAT Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: PHAT shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: PHAT shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: PHAT is currently trading at $13.81, which is considered slightly low relative to its 30-day fair value range of $13.74 to $16.41.
Technical Outlook: Technically, PHAT is in a strong uptrend. Immediate support is located at $13.14, while resistance sits at $14.68.
Market Sentiment: PHAT has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $22.90 (+65.8%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, PHAT is in a strong uptrend. Immediate support is located at $13.14, while resistance sits at $14.68.
Market Sentiment: PHAT has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $22.90 (+65.8%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Fair Price Range
$13.74 -
$16.41
Company Quality Score
55/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
57.9%
Protect Your Profits
Holding PHAT? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 65.8% below Wall St target ($22.90)
Fair Price Analysis
30-Day Fair Range
$13.74 -
$16.41
Current vs Fair Value
SLIGHTLY LOW
Support & Resistance Levels
Support Level
$13.14
Resistance Level
$14.68
Current Trend
Strong Uptrend
Fundamental Context
Forward P/E (Next Year Est.)
-123.52
Wall Street Target
$22.90
(+65.8%)
Revenue Growth (YoY)
202.7%
Profit Margin
-186.5%
Last updated: February 03, 2026 7:58 PM ET
Data refreshes hourly during market hours. Next update: 8:58 PM
Data refreshes hourly during market hours. Next update: 8:58 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is PHAT showing a specific setup today?
Insider Activity (6 Months)
0
Buys
1
Sells
Net
INSIDERS SELLING
Recent Transactions
Robert Charles Breedlove
SELL
461 shares
2025-09-05
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
LEGN
Legend Biotech Corp |
STRONG BUY
22 analysts |
$66 | 57 HOLD |
|
ACLX
Arcellx Inc |
STRONG BUY
18 analysts |
$112 | 57 HOLD |
|
MRUS
Merus BV |
STRONG BUY
17 analysts |
$97 | 55 HOLD |
|
BBIO
BridgeBio Pharma Inc |
STRONG BUY
19 analysts |
$93 | 59 HOLD |
|
RNA
Avidity Biosciences Inc |
STRONG BUY
15 analysts |
$75 | 59 HOLD |
Advanced PHAT Option Strategies
Professional options setups generated by AI based on today's PHAT price and gamma walls.
